Journal of Clinical and Translational Science (Jan 2021)

An overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center Experience

  • Elliott M. Antman,
  • Mason W. Freeman,
  • David E. Golan,
  • Roger Kitterman,
  • Erin McKenna,
  • John Parrish,
  • Cheryl Vaughan,
  • Lesley Watts,
  • Joseph Loscalzo

DOI
https://doi.org/10.1017/cts.2021.791
Journal volume & issue
Vol. 5

Abstract

Read online

Implementation of clinically useful research discoveries in the academic environment is challenged by limited funding for early phase proof-of-concept studies and inadequate expertise in product development and commercialization. To address these limitations, the National Institutes of Health (NIH) established the National Centers for Accelerated Innovations (NCAI) program in 2013. Three centers competed successfully for awards through this mechanism. Here, we present the experience of one such center, the Boston Biomedical Innovation Center (B-BIC), and demonstrate its remarkable success at the translation of innovations to clinical application and commercialization, as well as skills development and education.

Keywords